| Followers | 280 |
| Posts | 1175 |
| Boards Moderated | 0 |
| Alias Born | 10/04/2020 |
Wednesday, June 16, 2021 8:54:56 AM
BUY OUT Handwriting On The Wall- Common Sense Required
Well said 29! I would even go so far as to say a sure thing; a far gone conclusion! Likely a Big Pharma merger-acquisition to grab ALL of RGBP's 22 or more Patents, including the two active ones presently in the production pipeline via the CRO Oncology Pharma for treating pancreatic & colon cancer!
IF NOT then why the 4/23/21 8-K that served only ONE (1) purpose, i.e. to PREVENT A HOSTILE TAKE OVER DURING NEGOTIATIONS FOR THE SALE OF THE COMPANY!!! Koos even uses the language "directly negotiate" in the filing.
https://www.otcmarkets.com/filing/html?id=14894907&guid=ilRnUKwBhM5Jhth
Does anyone suppose that Koos spent his time, energy, and resources to file that 8-K because he had nothing else better to do??
There really is no other way to look at this, and as far as I'm concerned the only question remaining is WHEN & HOW MUCH?
The answer to this question will no doubt unfold in the immediate wake of RGBP going Pink Current straight ahead..days to weeks from now prior to the SEC deadline of Sept 28, 2021.
According to the information provided on the OTC Markets Link below, full disclosures "should" (NOT MUST) be made by June 30th to "allow sufficient time to review and update market status for the filing companies...."THIS IS NOT THE DEADLINE SO DON'T ANYONE GET IT TWISTED!!!
https://www.otcmarkets.com/corporate-services/information-for-pink-companies
Is this making any sense? If not it should.
Be well and prosper...
Well said 29! I would even go so far as to say a sure thing; a far gone conclusion! Likely a Big Pharma merger-acquisition to grab ALL of RGBP's 22 or more Patents, including the two active ones presently in the production pipeline via the CRO Oncology Pharma for treating pancreatic & colon cancer!
IF NOT then why the 4/23/21 8-K that served only ONE (1) purpose, i.e. to PREVENT A HOSTILE TAKE OVER DURING NEGOTIATIONS FOR THE SALE OF THE COMPANY!!! Koos even uses the language "directly negotiate" in the filing.
https://www.otcmarkets.com/filing/html?id=14894907&guid=ilRnUKwBhM5Jhth
Does anyone suppose that Koos spent his time, energy, and resources to file that 8-K because he had nothing else better to do??
There really is no other way to look at this, and as far as I'm concerned the only question remaining is WHEN & HOW MUCH?
The answer to this question will no doubt unfold in the immediate wake of RGBP going Pink Current straight ahead..days to weeks from now prior to the SEC deadline of Sept 28, 2021.
According to the information provided on the OTC Markets Link below, full disclosures "should" (NOT MUST) be made by June 30th to "allow sufficient time to review and update market status for the filing companies...."THIS IS NOT THE DEADLINE SO DON'T ANYONE GET IT TWISTED!!!
https://www.otcmarkets.com/corporate-services/information-for-pink-companies
Is this making any sense? If not it should.
Be well and prosper...
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
